Deutsche Bank Starts Intersect ENT (XENT) at Hold
Find out which companies are about to raise their dividend well before the news hits the Street with StreetInsider.com's Dividend Insider Elite. Sign-up for a FREE trial here.
Deutsche Bank initiated coverage on Intersect ENT (NASDAQ: XENT) with a Hold rating and a price target of $17.
Analyst Brittany Henderson thinks risk around execution and reimbursement offsets the company’s differentiated product platform in the near term.
Shares of Intersect ENT closed at $16.60 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- UPDATE: Cowen Downgrades Under Armour, Inc. (UA) to Market Perform
- Graphic Packaging (GPK) PT, Estimates Trimmed at Jefferies Post Q3
- Mizuho Securities Downgrades Under Armour, Inc. (UA) to Neutral Citing Structural Margin Challenges
Create E-mail Alert Related CategoriesAnalyst Comments, New Coverage
Related EntitiesDeutsche Bank
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!